Abstract:Objective:To investigate the effect of infliximab (IFX) on neurological function in mice after traumatic brain injury (TBI) and the role of nuclear factor-κB (NF-κB)/inducible nitric oxide lyase (iNOS) signaling in it.Methods:Seventy-two healthy adult male C57BL/6 mice were randomly divided into sham-operated group, TBI group, and TBI+IFX group ( n=24). The mouse TBI models were established by controlled cortical impact method. IFX (dissolved in normal saline at a concentration of 2.5 mg/mL and a dose of 10 μg/g) was administered intraperitoneally into the mice of TBI+IFX group 30 min after modeling once daily for 3 d; mice in the sham-operated group and TBI group were given the same amount of saline intraperitoneally at the same time points for 3 d. Neurological deficits (Garcia scores) were assessed one, 3 and 7 d after modeling; blood-brain barrier permeability was detected by Evans blue staining, and brain tissue water content was measured by dry and wet weight method; Nissl staining was used to detect the percentage of injured neurons in brain tissues; the percentage of apoptotic neurons was detected by Tunel staining; immunofluorescent double-labeling was used to detect the expressions of caspase-3 and neuronal nuclear antigen (NeuN) in neurons; immunohistochemical staining was used to detect the microglia marker ionized calcium binding adaptor molecule-1 (IBa-1) expression; ELISA was used to detect the expressions of inflammatory factors (tumor necrosis factor [TNF]-α, interleukin [IL]-1β, IL-6, interferon [IFN]-γ) and free radicals (oxygen free radicals [ROS], nitrogen free radicals [RNS]) in the brain tissues; and immunofluorescent staining and Western blotting were used to detect the expressions of nuclear factor (NF)-κB/inducible nitric oxide synthase (iNOS). Results:(1) One, 3 and 7 d after modeling, the Garcia scores showed significant differences among the three groups ( P<0.05); as compared with the TBI group, the TBI+IFX group had significantly increased Garcia scores 3 and 7 d after modeling ( P<0.05). (2) Three d after modeling, as compared with those in the TBI group, Evans blue leakage ([18.45±1.32] μg/g vs. [16.38±1.25] μg/g), brain water content ([81.56±0.96]% vs. [79.97±0.79]%), percentage of injured neurons ([79.50±5.85]% vs. [68.81±7.47]%), and percentage of apoptotic neurons ([41.93±7.49]% vs. [30.59±8.60]%) in mice of the TBI+IFX group were significantly deceased ( P<0.05). Three d after modeling, immunofluorescent double labeling showed that the relative caspase-3 expression in the TBI+IFX group (0.76±0.16) was significantly decreased as compared with the TBI group (1.11±0.23, P<0.05). Immunohistochemical staining and ELISA results showed that as compared with those in the TBI group, the Iba-1 staining scores, TNF-α, IL-1β, IL6 and IFN-γ levels, and ROS and RNS contents in TBI+IFX group were significantly decreased ( P<0.05). Immunofluorescent staining and Western blotting showed that as compared with the TBI group, the TBI+IFX group had significantly decreased expressions of NF-κB p65, iNOS and phosphorylated nuclear factor-κB inhibitor-α, and statistically inhibited nuclear translocation of NF-κB ( P<0.05). Conclusion:IFX can reduce inflammatory response and oxidative stress response, and play a neuroprotective role, which is related to its inhibition of downstream NF-κB/iNOS pathway activation.

Therapeutic Effect Of Sn50, An Inhibitor Of Nuclear Factor-Kappa B, In Treatment Of Tbi In Mice

Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice

Disruption of Nrf2 Enhances Upregulation of Nuclear Factor-κB Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule-1 in the Brain after Traumatic Brain Injury

Neuroprotective Effects of (-)-epicatechin on Traumatic Brain Injury Mice by Nuclear Factor E2-related Factor 2 Pathway

Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway

TAK-242, a Toll-Like Receptor 4 Antagonist, Against Brain Injury by Alleviates Autophagy and Inflammation in Rats

Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo.

Tachykinin NK1 Receptor Antagonist L-733,060 and Substance P Deletion Exert Neuroprotection Through Inhibiting Oxidative Stress and Cell Death after Traumatic Brain Injury in Mice

Protective effect of infliximab on neurological function and its related mechanism in mice after traumatic brain injury

Expression of Autophagy Related Proteins Regulated by Nuclear Factor-κB after Intracerebral Hemorrhage in Mice

Brain-protecting Effect of Β2-Adrenoceptor Antagonist in Rats with Traumatic Brain Injury

The Expression of Nuclear Factor-Κb and Tumor Necrosis Factor-Α Following Brain Injury in Rats

Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome

Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis Through the Camp/pka/nlrp3 Pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway.

Inhibition of neutrophil extracellular trap formation ameliorates neuroinflammation and neuronal apoptosis via STING-dependent IRE1α/ASK1/JNK signaling pathway in mice with traumatic brain injury

Xyloketal derivative C53N protects against mild traumatic brain injury in mice.

Inhibition of Na +-K +-2Cl-cotransporter-1 Attenuates Traumatic Brain Injury in Mouse

Intranasal delivery of nerve growth factor attenuates neuroinflammation following traumatic brain injury in rats

The Effect of Tetramethylpyrazine on the Expression of NF-KB and I-KBa after Acute Spinal Cord Injury in the Rat Model

Inhibition of Na+-K+-2Cl− Cotransporter Attenuates Blood-Brain-barrier Disruption in a Mouse Model of Traumatic Brain Injury